Akido expands AI‑powered patient intake and diagnostic support across 100 clinics in the US

Akido, an AI-focused healthcare startup, has announced that it is expanding its proprietary AI platform, ScopeAI, across 100 clinics, virtual care operations, and street/field medicine programs, forming what it calls the first AI-native health system in the United States.

ScopeAI functions as an ambient clinical intelligence engine that listens during patient encounters, organizes clinical information in real time, and provides physicians with a diagnostic head start, freeing them from administrative tasks and allowing more direct patient interaction.

The expanded network now provides care access to approximately 1 million patients across California, New York City, and Rhode Island, combining brick‑and‑mortar clinics, telehealth, and mobile field teams serving vulnerable populations such as unhoused individuals in Los Angeles.

Early data from Akido’s LA street medicine program—using ScopeAI on iPads—show a 55% reduction in Emergency Department utilization and 53% same‑day access to ongoing care, while clinicians report up to five times more face‑to‑face time per visit and a Net Promoter Score around 96.

ScopeAI is designed to be human‑centric, with medical assistants or community health workers guiding intake while the AI generates notes, differential diagnoses, and treatment suggestions; a physician always reviews and approves the final plan, ensuring the system operates as an assistant rather than a standalone “doctor in a box.”